🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

148,46 USD

Máx. histórico

156,92

14 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,39%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,24%

Cierre anterior

150,33

Rango de hoy

146,28 – 149,59

Volumen hoy

10.884.998

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER
118,77 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
150,42 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,26%
Fecha de pago Importe por participación
31/08/1981 0,0172 USD
01/06/1981 0,0172 USD
02/03/1981 0,0172 USD
02/12/1980 0,0172 USD
29/08/1980 0,0152 USD
02/06/1980 0,0152 USD
28/02/1980 0,0152 USD
03/12/1979 0,0152 USD
31/08/1979 0,0126 USD
25/05/1979 0,0126 USD
01/03/1979 0,0126 USD
04/12/1978 0,0126 USD
28/08/1978 0,0113 USD
26/05/1978 0,0113 USD
02/03/1978 0,0113 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
11/01/2001 79,68 79,79 77,17 77,89 -1,88% 3,29% 6.979.575
10/01/2001 80,21 80,93 78,30 79,38 -0,97% 3,27% 6.469.199
09/01/2001 80,09 81,11 79,26 80,15 +0,60% 2,31% 6.389.761
08/01/2001 80,15 80,63 78,90 79,68 +0,23% 2,16% 5.143.165
05/01/2001 81,11 81,88 79,32 79,50 -1,99% 3,16% 9.799.324
04/01/2001 84,39 84,51 79,91 81,11 -4,63% 5,44% 19.205.543
03/01/2001 88,56 88,74 84,09 85,04 -4,17% 5,25% 10.308.128
02/01/2001 89,10 90,89 88,26 88,74 -0,67% 2,95% 6.332.959
29/12/2000 90,65 91,54 89,16 89,34 -1,19% 2,63% 3.916.481
28/12/2000 89,34 90,41 89,16 90,41 +2,23% 1,40% 3.281.917
27/12/2000 88,50 90,35 88,38 88,44 +0,00% 2,22% 5.269.658
26/12/2000 86,71 88,98 86,30 88,44 +2,42% 3,09% 3.810.842
22/12/2000 88,62 88,62 86,12 86,36 -2,16% 2,83% 5.113.611
21/12/2000 88,74 89,34 86,83 88,26 -0,94% 2,82% 7.699.970
20/12/2000 88,74 90,77 88,20 89,10 +2,05% 2,89% 10.115.191
19/12/2000 84,09 88,08 84,09 87,31 +2,45% 4,75% 5.295.230
18/12/2000 85,88 86,30 84,74 85,22 -1,18% 1,81% 5.236.122
15/12/2000 86,83 87,79 85,76 86,24 -0,69% 2,34% 11.178.387
14/12/2000 87,13 87,55 86,53 86,83 -1,09% 1,16% 3.764.521
13/12/2000 86,71 88,02 86,65 87,79 +0,68% 1,58% 7.702.905
12/12/2000 86,53 87,37 86,36 87,19 +0,83% 1,17% 6.351.299
11/12/2000 85,88 87,19 85,70 86,47 +1,19% 1,74% 5.117.698
08/12/2000 85,88 87,07 84,63 85,46 -1,65% 2,85% 7.013.006
07/12/2000 86,36 87,25 85,28 86,89 +1,67% 2,28% 4.519.605
06/12/2000 85,04 86,36 84,45 85,46 -0,49% 2,24% 6.040.882
05/12/2000 88,26 88,26 84,39 85,88 -2,11% 4,39% 8.278.571
04/12/2000 84,45 88,68 84,45 87,73 +1,45% 5,01% 6.431.681
01/12/2000 87,31 87,85 85,04 86,47 -2,23% 3,21% 7.942.582
30/11/2000 91,36 92,26 88,02 88,44 -2,31% 4,63% 9.563.524
29/11/2000 88,74 90,83 88,74 90,53 +2,43% 2,35% 8.727.744